| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |